...
首页> 外文期刊>Cellular and Molecular Bioengineering >Biological Assessments of Encapsulated Pancreatic beta-Cells: Their Potential Transplantation in Diabetes
【24h】

Biological Assessments of Encapsulated Pancreatic beta-Cells: Their Potential Transplantation in Diabetes

机译:封装的胰腺β细胞的生物学评估:在糖尿病中潜在的移植。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Microencapsulation of pancreatic islets has been considered as a promising method for cell transplantation and diabetes treatment. However, in vivo trials to date have been hampered by fibrotic overgrowth and very limited to no success, long-term. Future success requires suitable microencapsulating method and possibly a simplified and suitable formulation which will produce a microcapsule that provides an immunobarrier, maintain full beta-cell functionality whilst also reducing the inflammatory processes that induce fibrosis. In multiple studies, we screened various formulations and microencapsulating methods, and obtained promising results using bile acid-based microcapsules containing beta-cells, in terms of cell functions and insulin release. Thus, this study aimed to refine further the microencapsulating method using a simple alginate-poly-l-ornithine formulation and test the effect of adding a promising bile acid, ursodeoxycholic acid (UDCA), on cell functions. Using Buchi concentric nozzle, viable NIT-1 cells were microencapsulated using alginate-poly-l-ornithine, with or without UDCA at a ratio of 1:1.2 or 1:1.2:4. Screening for nozzle temperature and nozzle-gelation bath distance was carried out to form best microcapsules. Microcapsules were cultured for 48 h and examined for size and surface morphology, chemical profiling and beta-cell viability. Culture supernatants were examined for insulin and inflammatory cytokines. When using 30 A degrees C nozzle-temperature and 5 cm nozzle-gelation bath distance, in the presence of the bile acid, cell mitochondrial activities and insulin production were optimised. Under deployed microencapsulating method with nozzle-temperature of 30 A degrees C and nozzle-gelation bath distance of 5 cm, the incorporation of the bile acid into the microcapsules resulted in enhanced beta-cell survival, function and improved overall biocompatibility supporting potential applications in transplantation.
机译:胰岛的微囊化已被认为是用于细胞移植和糖尿病治疗的有前途的方法。然而,迄今为止,体内试验受到纤维化过度生长的阻碍,并且长期仅限于没有成功。未来的成功需要合适的微囊化方法以及可能的简化和合适的制剂,该制剂将产生提供免疫屏障,维持完整的β-细胞功能性同时减少诱导纤维化的炎症过程的微胶囊。在多项研究中,我们筛选了各种制剂和微囊化方法,并在细胞功能和胰岛素释放方面使用了含有β细胞的胆汁酸微胶囊,获得了可喜的结果。因此,本研究旨在进一步改进使用简单藻酸盐-聚-1-鸟氨酸制剂的微囊化方法,并测试添加有希望的胆汁酸熊去氧胆酸(UDCA)对细胞功能的影响。使用Buchi同心喷嘴,使用藻酸盐-聚-1-鸟氨酸,在有或没有UDCA的情况下以1:1.2或1:1.2:4的比例微囊化存活的NIT-1细胞。进行喷嘴温度和喷嘴-胶凝浴距离的筛选以形成最佳的微胶囊。微囊培养48小时,并检查其大小和表面形态,化学谱和β细胞活力。检查培养上清液中的胰岛素和炎性细胞因子。当使用30 A的喷嘴温度和5 cm的喷嘴-胶凝浴距离时,在胆汁酸的存在下,细胞线粒体活性和胰岛素生产得以优化。在喷嘴温度为30 A且喷嘴凝胶浴距离为5 cm的已部署微胶囊化方法下,将胆汁酸掺入微胶囊可提高β细胞的存活率,功能并改善整体生物相容性,从而支持潜在的移植应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号